Literature DB >> 3917598

Incomplete and delayed bioavailability of sublingual nitroglycerin.

P K Noonan, L Z Benet.   

Abstract

Eight healthy male volunteers received 16 doses of sublingual nitroglycerin tablets (0.4 mg). After 8 minutes, each subject rinsed out his mouth to halt the drug absorption process. The mouth rinses were assayed by high-performance liquid chromatography for residual nitroglycerin content. Each subject also received intravenous infusions of nitroglycerin so that the absolute bioavailability could be evaluated. Plasma nitroglycerin concentrations were determined using a specific and sensitive capillary gas chromatographic method capable of quantifying 25 pg/ml of nitroglycerin. The mean bioavailability (+/- standard deviation) of sublingual nitroglycerin, estimated from plasma concentrations, was 36.2 +/- 24.9% (range 2.6 to 113%). The amount of drug not absorbed after 8 minutes, as determined from the analysis of the mouth rinses, varied from 2.7 to 65.8% (mean 31.4 +/- 18.9%) of the administered sublingual dose. Mean nitroglycerin peak concentrations of 1.89 +/- 1.64 ng/ml were obtained at a mean peak time of 5.3 +/- 2.3 minutes. Thus, sublingual absorption is not instantaneous and can be relatively slow, with peak times of as long as 10 minutes. These data indicate that nitroglycerin pharmacokinetic values should not be estimated only from sublingual doses. Additionally, attempts to correlate pharmacodynamic measurements to sublingual doses must take into account the low and variable bioavailability and the potentially long peak times after sublingual nitroglycerin administration to patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917598     DOI: 10.1016/0002-9149(85)90325-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  15 in total

1.  Acute decompensated heart failure.

Authors:  Howard A Smithline
Journal:  CMAJ       Date:  2007-07-17       Impact factor: 8.262

Review 2.  Anesthesia for myelomeningocele surgery in fetus.

Authors:  Juan Carlos Devoto; Juan Luis Alcalde; Felipe Otayza; Waldo Sepulveda
Journal:  Childs Nerv Syst       Date:  2017-05-25       Impact factor: 1.475

3.  Sublingual nitroglycerin. II. In vitro and in vivo availability of Nitrostat and Nitrobaat tablets.

Authors:  M Lagas; A M Duchateau
Journal:  Pharm Weekbl Sci       Date:  1988-12-09

4.  Imaging transcranial Doppler ultrasound to measure middle cerebral artery blood flow: the importance of measuring vessel diameter.

Authors:  Catherine L Jarrett; Katherine L Shields; Ryan M Broxterman; Jay R Hydren; Soung Hun Park; Jayson R Gifford; Russell S Richardson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-05-13       Impact factor: 3.619

Review 5.  Clinical pharmacokinetics of nitrates.

Authors:  M G Bogaert
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

Review 6.  Organic nitrate metabolism and action: toward a unifying hypothesis and the future-a dedication to Professor Leslie Z. Benet.

Authors:  Nathaniel A Page; Ho-Leung Fung
Journal:  J Pharm Sci       Date:  2013-05-13       Impact factor: 3.534

7.  Mechanisms mediating nitroglycerin-induced delayed-onset hyperalgesia in the rat.

Authors:  L F Ferrari; J D Levine; P G Green
Journal:  Neuroscience       Date:  2016-01-11       Impact factor: 3.590

Review 8.  Relationship of pharmacokinetic and pharmacodynamic properties of the organic nitrates.

Authors:  U Thadani; T Whitsett
Journal:  Clin Pharmacokinet       Date:  1988-07       Impact factor: 6.447

9.  Haemodynamic, anti-anginal and anti-ischaemic effects of sublingual nitroglycerin: dose-response, duration and time of onset of action.

Authors:  G Nyberg; B Holmberg
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

10.  Intracranial hemodynamics during intravenous infusion of glyceryl trinitrate.

Authors:  H K Iversen; S Holm; L Friberg; P Tfelt-Hansen
Journal:  J Headache Pain       Date:  2008-04-10       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.